Athenex, Inc. (65) | Purchase Agreements (3)
Recent Contracts
-
Limited Waiver under Revenue Interest Purchase Agreement, by and among ATNX SPV, LLC, Athenex, Inc., and the Purchaser parties thereto, dated as of August 14, 2022
(Filed With SEC on August 18, 2022)
-
Purchase Agreement, by and between Athenex, Inc. and ImmunityBio, Inc. dated January 7, 2022
(Filed With SEC on January 12, 2022)
-
Asset Purchase and Sale Agreement dated as of September 1, 2020 by and between Athenex Pharmaceutical Division, LLC and Ingenus Pharmaceuticals, LLC
(Filed With SEC on March 1, 2021)
